286
Participants
Start Date
October 1, 2021
Primary Completion Date
July 31, 2025
Study Completion Date
January 31, 2026
Antiarrhythmic drug including Propafenone, Sotalol, Dronedarone and Amiodarone
Class I or III antiarrhythmic drug, including sotalol
cryoballoon ablation
Pulmonary vein isolation by cryoballoon ablation using Medtronic Arctic Front Advance™ Cardiac CryoAblation Catheters (23mm and 28mm)
RECRUITING
Ruijin Hospital, Shanghai
RECRUITING
Shanghai Tenth People's Hospital, Shanghai
RECRUITING
Nanjing Drum Tower hospital, Nanjing
RECRUITING
Zhongda Hospital Southeast University, Nanjing
RECRUITING
Xuzhou Central Hospital, Xuzhou
RECRUITING
Jiangsu Taizhou People's Hospital, Taizhou
RECRUITING
Affiliated Hospital Of Nantong University, Nantong
RECRUITING
Qilu Hospital Of Shandong University, Jinan
RECRUITING
Tianjin Chest Hospital, Tianjin
RECRUITING
The Second Hospital Of Tianjin Medical University, Tianjin
RECRUITING
Fujian Provincial Hospital, Fuzhou
RECRUITING
Sun Yat-sen Memorial Hospital, Guangzhou
RECRUITING
The First Affiliated Hospital,Sun Yat-sen University, Guangzhou
RECRUITING
Dongguan People's Hospital, Dongguan
RECRUITING
The Affiliated Hospital Of Guizhou Medical University, Guiyang
RECRUITING
"West China School of Medicine /West China Hospital of Sichuan University ", Chengdu
RECRUITING
The First Affiliated Hospital of Xinjiang Medical University, Ürümqi
Ruijin Hospital
OTHER